FindTrial
Sign In

Analysis of the risk of diseases after hysterectomy after adjusting for polycystic ovary syndrome

Analysis of the risk of diseases after hysterectomy after adjusting for polycystic ovary syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0008843
Enrollment
1272999
Registered
2023-10-06
Start date
2022-06-27
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Inje University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Inclusion Criteria: Women aged 40 to 60 years who underwent hysterectomy for benign diseases (including stage 0 cancer) from 2002 to 2011 and underwent medical examination (including cancer screening) at this time. Inclusion Criteria: Women aged 40 to 60 years who underwent medical examination (including cancer screening) for benign diseases (including stage 0 cancer) from 2002 to 2011.

Exclusion criteria

Exclusion criteria: Diagnosed with a malignant neoplasm prior to hysterectomy (diagnosis code C)

Design outcomes

Primary

MeasureTime frame
Neoplasms—

Secondary

MeasureTime frame
pelvic organ prolapse, osteoporosis, hypertension, Cataracts, dementia, and thyroid disease—

Countries

Korea, Republic of

Contacts

Public ContactJin-Sung Yuk

Inje University

cnnsbs@naver.com+82-2-950-1057

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026